We have investigated the potential for protein kinase C (PKC) to phosphorylate and desensitize the ␣ 2A -adrenergic receptor (␣ 2A AR). In whole-cell phosphorylation studies, recombinantly expressed human ␣ 2A AR displayed an increase in phosphorylation after short-term exposure to 100 nM phorbol 12-myristate-13-acetate (PMA) that was blocked by preincubation with a PKC inhibitor. This increase in receptor phosphorylation over basal amounted to 172 Ϯ 40% in COS-7 cells and 201 Ϯ 40% in Chinese hamster ovary cells. In permanently transfected Chinese hamster fibroblast cells, PKC activation by brief exposure of the cells to PMA resulted in a marked desensitization of ␣ 2A AR function, amounting to a 68 Ϯ 4% decrease in the maximal agonist (UK14304)-stimulated intracellular calcium release. Such desensitization was blocked by the PKC inhibitor bisindolylmaleimide I and was not evoked by an inactive phorbol ester. The desensitization of this agonist response was not caused by PKC-mediated augmentation of G protein-coupled receptor kinase activity, because PMA-promoted desensitization of a mutated ␣ 2A AR that lacked G protein-coupled receptor kinase phosphorylation sites was identical to that of wild-type ␣ 2A AR. To test whether PKC phosphorylation is a mechanism by which ␣ 2A AR can be regulated by other receptors, the ␣ 1b AR was co-expressed with the ␣ 2A AR in Chinese hamster ovary cells. Upon selective activation of ␣ 1b AR, the function of ␣ 2A AR underwent a 53 Ϯ 5% desensitization. Thus, cellular events that result in PKC activation promote phosphorylation of the ␣ 2A AR and lead to substantial desensitization of receptor function. This heterologous regulation also represents a mechanism by which rapid crosstalk between the ␣ 2A AR and other receptors can occur.
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The ␣ 2 ARs regulate several effector systems including adenylyl cyclase, potassium channels, calcium channels, and inositol phosphate-mediated intracellular calcium release (Limbird, 1988; Liggett, 1996; Akerman et al. 1997; . Studies in intact organisms and cell culture systems have indicated that the function of G protein-coupled receptors, including ␣ 2 ARs, can be dynamically regulated under various physiologic and pathophysiologic conditions (Liggett and Lefkowitz, 1993; Liggett, 1997) . We have recently delineated one pathway whereby persistent agonist activation results in a dampening of ␣ 2 AR signaling, termed desensitization, which is due to receptor phosphorylation by GRKs (Eason and Liggett, 1992; Liggett et al., 1992; Eason et al., 1995) . GRK-mediated desensitization is evoked by agonist occupancy of the receptor, is independent of the generation of second messengers, and represents one mechanism of homologous desensitization of the ␣ 2 AR. The molecular basis of heterologous regulation of ␣ 2 AR has been largely unexplored. In the current study, we investigated the regulation of ␣ 2 AR signaling by PKC. This kinase was found to phosphorylate the ␣ 2A subtype, which resulted in a rapid desensitization of receptor function. These effects represent a mechanism by which crosstalk between ␣ 2 AR and other G protein-coupled receptors can occur.
Experimental Procedures
Constructs and transfections. The human ␣ 2A AR cDNA and a construct encoding a mutated ␣ 2A AR lacking the four GRK phosphorylation sites in the third intracellular loop were in the mammalian expression vector pBC12BI as described previously (Eason et al., 1995) . The hamster ␣ 1b AR cDNA was inserted into pRK5. For transient expression of wild-type ␣ 2 AR, COS-7 cells in monolayers at ϳ30-50% confluence were transfected with 10 g of the ␣ 2A AR construct via the DEAE-dextran method as described previously (Jewell-Motz and Liggett, 1996) . Cells were then used for experiments 48 hr after transfection. COS-7 cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum, 100 units/ml penicillin, and 100 g/ml streptomycin at 37°in a 5% CO 2 atmosphere. For permanent expression of ␣ 2 AR, CHO cells in monolayers at ϳ30% confluence were cotransfected with the use of a calcium phosphate precipitation method. Cells were transfected with 3 g of pSV 2 neo, which provides G-418 resistance, and 20 g of the ␣ 2 AR construct. A similar approach was used to co-express the ␣ 2A AR and ␣ 1b AR receptor by simultaneous transfections with 10 g of each receptor construct. Screening for ␣ 2A AR expression was by a [ 3 H]yohimbine binding assay and screening for the ␣ 1b AR by a [
125 I]HEAT binding assay, as described below. CHO cells were maintained in Ham's F-12 medium supplemented with 10% fetal bovine serum, 100 units/ml penicillin, 100 g/ml streptomycin, and 80 g/ml G-418 (to maintain selection pressure) at 37°in a 5% CO 2 atmosphere.
Desensitization of calcium signaling. CHO cells were detached, washed, and loaded with Fura-2/AM as described previously . Cells in 3.0 ml aliquots (ϳ4 ϫ 10 6 cells) at 37°w ere then added to cuvettes and after baseline measurements were obtained, the increases in intracellular calcium in response to the indicated concentrations of ␣ 2 AR agonists or 0.3 units/ml thrombin were determined over the ensuing 2 min by using standard methods exactly as described previously . Routinely, cells were incubated with PMA at the indicated concentrations for 1 min before the addition of the agonist. ␣ 2A AR desensitization was defined as follows:
where [Ca 2ϩ ] i is the change in intracellular free calcium concentration evoked by the agonist in untreated cells (pre) or in cells after exposure to desensitizing agent (post). For cells expressing ␣ 2A AR and ␣ 1b AR, we were interested in the effects of selective activation of ␣ 1b AR on ␣ 2A AR function. These studies were carried out with a 1.0-M concentration of the agonist phenylephrine, which was incubated with the cells for 10 min in the presence of 10 M yohimbine (to block any activation of ␣ 2 AR by the phenylephrine). Control cells were incubated with yohimbine alone. Cells were then washed three times with 30 volumes of cold buffer to remove both agents, and then challenged with 1.0 M UK14304 to assess ␣ 2A AR stimulation of intracellular calcium release as above.
␣ 2 AR phosphorylation. Whole cell phosphorylation studies were carried out in a manner similar to that described previously (Eason et al., 1995; Jewell-Motz and Liggett, 1996) . Briefly, COS-7 cells transiently co-expressing ␣ 2A AR were incubated with [ 32 P]orthophosphate (ϳ2.4 mCi/150-cm 2 plate) for 2 hr at 37°in 5% CO 2 . Cells were then incubated for the indicated times with the medium alone or the medium plus the indicated concentrations of PMA or the agonist UK14304, washed five times with ice-cold phosphate-buffered saline, and scraped in buffer containing 10 mM Tris⅐HCl, pH 7.4, 5 mM EDTA, 5 mM EGTA, 10 mM NaF, 10 mM sodium pyrophosphate, and 5 g/ml of the protease inhibitors benzamidine, soybean trypsin inhibitor, and leupeptin, which were included in this and all subsequent steps. Particulates were centrifuged at 40,000 ϫ g for 10 min at 4°, and the resulting pellet was resuspended in the previously mentioned buffer, sonicated for 15 sec, and centrifuged once again. The receptor was then purified by immunoprecipitation as described previously (Eason et al., 1995; Jewell-Motz and Liggett, 1996) . Briefly, membranes were solubilized by stirring in phosphate-buffered saline containing 1% Triton X-100, 0.05% SDS, 1 mM EDTA, and 1 mM EGTA for 2 hr at 4°. Unsolubilized material was removed by centrifugation at 40,000 ϫ g for 20 min at 4°, and the solubilized material was incubated with preimmune serum and protein A-Sepharose beads for 30 min at room temperature. The beads containing nonspecific immunoprecipitant were removed by brief centrifugation, and the remaining supernatant was incubated with a 1:200 dilution of polyclonal ␣ 2A AR antisera (Kurose et al., 1993) and protein A-Sepharose beads for 16 hr at 4°. The beads were washed five times, sonicated in SDS-sample buffer, and removed by centrifugation. The released immunoprecipitates containing equal amounts of receptor were fractionated on 10% SDS-polyacrylamide gels. Autoradiography was used to detect phosphorylation of receptors, and the amount of radioactivity was quantified on a PhosphorImager with ImageQuant software (Molecular Dynamics, Sunnyvale, CA). For presentation purposes, autoradiograms were produced by exposing the gels to X-ray film for ϳ16 hr.
Radioligand binding. Expression levels of ␣ 2A AR were determined using a [ 3 H]yohimbine binding assay. Membranes prepared as described above were incubated with 25 nM [ 3 H]yohimbine in the absence or presence of 10 M phentolamine, which was used to define nonspecific binding, in a buffer containing 75 mM Tris, pH 7.4, 12.5 mM MgCl 2 , and 2 mM EDTA for 30 min at 25°. For determination of ]HEAT in the absence or presence of 10 M phentolamine for 20 min at 25°. Reactions were terminated by dilution with ice-cold 10 mM Tris, pH 7.4, followed by vacuum filtration through GF/C glass fiber filters (Whatman, Clifton, NJ). Specific binding was normalized for protein. For the current studies, CHO cells expressing wild-type ␣ 2A AR at 1081 Ϯ 80 fmol/mg and the GRK deletion mutant at 1770 Ϯ 126 fmol/mg were used. For the CHO co-expression studies ␣ 2A AR density was 3.1 Ϯ 0.2 pmol/mg and ␣ 1b AR density was 355 Ϯ 75 fmol/mg. In COS-7 cells, transient expression of ␣ 2A AR at levels of 5-7 pmol/mg was attained.
Miscellaneous. Western blots of cytosolic and membrane fractions of CHO cells using antisera agonist PKC isoforms ␣, ␤, ␦, ⑀, and were carried out as described (D'Angelo et al., 1997) and visualized using the enhanced chemiluminescence system from New England Nuclear (Boston, MA). Protein concentrations were determined by the copper bicinchoninic method (Smith et al., 1985) .
Materials. PMA and the inactive phorbol ester 4␣-phorbol-12,13-didecanoate were purchased from Sigma (St. Louis, MO). Bisindolylmaleimide I was obtained from Calbiochem (San Diego, CA). The isoform-specific PKC antisera were from Santa Cruz Biotechnology (Santa Cruz, CA) and Transduction Laboratories (Lexington, KY). The hamster ␣ 1b AR construct was provided by D. Schwinn (Duke University Medical Center, Durham, NC). Sources for all other reagents were as referenced elsewhere (Eason et al., 1995; Dorn et al., 1997) .
Results and Discussion
To assess the potential for PKC to regulate ␣ 2A AR function, the receptor was transiently overexpressed in COS-7 cells and intact cell phosphorylation studies were carried out. As shown in Fig. 1A , exposure of cells to the PKC activator PMA indeed resulted in receptor phosphorylation that was rapid (maximal response occurred at ϳ3 min), with concentrations of 0.1-0.5 M giving the maximal response. The extent of PMA-promoted receptor phosphorylation under optimal conditions was found to be 172 Ϯ 14% (n ϭ 38, where n indicates the number of experiments) above basal levels, whereas phosphorylation by the ␣ 2 AR agonist UK14304 was 219 Ϯ 30% (n ϭ 15) over basal (Fig. 1B) . Because we planned to assess the functional consequences of PKC-mediated phosphorylation in CHO cells that permanently expressed the receptor at lower levels, additional phosphorylation studies were carried out in these cells as well to confirm that the pathway is also intact in CHO cells. As shown in Fig. 2 , PMA did promote receptor phosphorylation in these cells to 201 Ϯ 40% over basal. Again, the extent of PMA phosphorylation was less than that of UK14304-promoted phosphorylation, which amounted to 336 Ϯ 31% over basal. As is shown, PMA-promoted phosphorylation of ␣ 2A AR was completely abolished by pre-exposure to 1 M of the PKC inhibitor staurosporine. Although the basal levels of phosphorylation were lowered, the fold stimulation of phosphorylation over basal induced by UK14304 was not altered by staurosporine.
To investigate whether PKC-mediated receptor phosphorylation altered ␣ 2 AR function, we examined ␣ 2 AR-mediated stimulation of intracellular calcium release. This signaling pathway is due to receptor coupling to G i with subsequent ␤␥ release that activates PLC . As shown in Fig. 3A , 100 nM PMA exposure for 1 min results in a significant decrease in ␣ 2A AR-mediated calcium signaling. In doseresponse studies, maximum desensitization occurred with 100 nM of PMA, and the calculated concentration of PMA that evoked a half maximal desensitization response was ϳ10 nM (Fig. 4) . PMA desensitization was blocked by pretreatment of the cells for 10 min with the PKC inhibitor bisindolylmaleimide I (1 M), whereas treatment with the inactive phorbol ester 4␣-phorbol-12,13-didecanoate (100 nM) had no effect on ␣ 2 AR-calcium signaling (n ϭ 4; Fig. 5 ). In 15 studies, 100 nM pretreatment with PMA was found to evoke a 68 Ϯ 4% desensitization of ␣ 2 AR-calcium signaling (Figs. 3A, 5) . In contrast, thrombin-mediated stimulation of intracellular calcium release, which occurs via a G q/11 -stimulated PLC pathway in CHO cells , displayed 26 Ϯ 6% desensitization by PMA (Figs. 3B, 5) . The desensitization by PMA was also observed when ␣ 2 ARs were subsequently activated by the endogenous catecholamines epinephrine and norepinephrine. The extent of desensitization under these conditions was virtually the same (53% Ϯ 3 with epinephrine and 66% Ϯ 9 with norepinephrine; n ϭ 6) as when the agent UK14304 was used for activation.
Upon phosphorylation by PKC, ␤ARK activity (Deblasi et al., 1995) and translocation (Freund et al., 1996) are enhanced. Thus, we considered that an alternative explanation for the desensitization of the agonist responsiveness of ␣ 2 AR induced by PMA exposure could be these effects on ␤ARK. To address this, studies were carried out with a mutated ␣ 2A AR lacking the four serines in the third intracellular loop that are phosphorylated by ␤ARK (Eason et al., 1995) . PMAinduced desensitization of agonist stimulation of intracellular calcium release occurred to the same extent (65 Ϯ 2%, n ϭ 4) with this mutated receptor as with the wild-type ␣ 2A AR (Fig. 5) .
Given these results, we considered that activation of PKC by another receptor should induce desensitization of the ␣ 2A AR. This potential crosstalk was assessed by co-expression of the Gq-coupled ␣ 1b AR with the ␣ 2A AR in CHO cells and selective activation of the ␣ 1 AR. As shown in Fig. 5 , activation of the ␣ 1b AR indeed resulted in depressed maximal ␣ 2A AR stimulation of intracellular calcium release. The extent of this desensitization amounted to 53 Ϯ 5% (n ϭ 4). Again, thrombin signaling under the same conditions was minimally desensitized.
The PKC isoforms expressed in CHO cells were determined with Western blots using antisera directed against the ␣, ␤, (Fig. 6) . PKC ␣, ⑀, and , but not ␤ or ␦, were expressed, and consistent with the known sensitivity of conventional and novel PKCs, but not atypical PKCs, to diacylglycerol analogues (Hug and Sarre, 1993) , the ␣ and ⑀ isoforms translocated to the membrane upon exposure of the cells to PMA. Thus, in regard to the PMA effects on ␣ 2A AR function observed in CHO cells, it seems that these are mediated by PKC ␣ and/or PKC ⑀ . We also assessed which PKC isoforms were translocated as a result of ␣ 2A AR and ␣ 1b AR activation. All three isoforms were translocated by ␣ 2A AR, whereas ␣ 1b AR activation was associated with translocation of the ␣ and isoforms.
Recent studies have shown that ␣ 2A AR expressed in CHO, COS-7, and human embryonic kidney 293 cells undergo rapid phosphorylation and homologous desensitization during agonist occupancy (Eason and Liggett, 1992; Liggett et al., 1992; Kurose and Lefkowitz, 1994; Eason et al., 1995; JewellMotz and Liggett, 1996) With the use of several different approaches, homologous desensitization of ␣ 2A AR has been shown to be caused by rapid phosphorylation of the receptor. One kinase that has been implicated in this process is the ␤ARK or related G protein-coupled receptor kinases. Some evidence, however, indicates that ␣ 2 AR function can be regulated by other kinases. For the rapid form of heterologous desensitization, PKC phosphorylation has been considered a likely candidate mechanism for the ␣ 2 AR and several other G protein-coupled receptors. Convents et al. (1989) have shown that PMA exposure to NG108 cells, which express the ␣ 2B subtype, results in a loss of ␣ 2 AR inhibition of cAMP production, but no change in the response to carbachol. For the ␣ 1 AR, PMA pretreatment results in phosphorylation of the receptor and decreased coupling to phosphoinositide hydrolysis . ␤ 2 AR function has also been shown to be decreased by phorbol esters, an effect associated with receptor phosphorylation (Bouvier et al. 1991) . One of the most well characterized G protein-coupled receptor signaling pathways that is altered by PKC-mediated receptor phosphorylation is that of the 5HT 1A receptor (Raymond, 1991) , where the sites of this phosphorylation recently have been mapped (Lembo and Albert, 1995) .
A possible confounding factor in our current work has been the potential for phorbol esters to modify signal transduction at multiple levels, from the receptor to the measured outcome (intracellular calcium release). PKC has been reported to phosphorylate G i (Katada et al., 1985) , and if this occurred in the intact cell experiments of our study, it would make interpretation of receptor-specific desensitization difficult. However, this has been addressed in the aforementioned studies of PKC phosphorylation and desensitization of the G i coupled 5HT 1A receptor (Lembo and Albert, 1995) . In these studies, when all PKC sites were ablated in this receptor, phorbol esters had minimal effects on receptor signaling, which suggests that G i function remains relatively intact with experiments such as those in the current report involving brief exposure (minutes) to phorbol esters. Phorbol esters have also been reported to phosphorylate the effector PLC␤ (Ryu et al., 1990) . We therefore used thrombin signaling as a control, because this receptor ultimately activates PLC as well. Under the conditions used here, thrombin-stimulated release of intracellular calcium was desensitized only 15-25% by PMA although the ␣ 2A AR response was desensitized by ϳ70%. Similarly, desensitization of the inositol phosphate receptor or depletion of calcium stores would result in de- creased intracellular calcium release. Again, however, such desensitization would also be expected with thrombin receptor signaling, which was not desensitized to nearly the same extent as was ␣ 2 AR signaling. The possibility that PKC could alter a portion of the ␣ 2 AR signal-transduction pathway that would not be accounted for by our controls must nevertheless be considered.
We initially investigated PKC-mediated ␣ 2A AR phosphorylation by expressing the receptor in COS-7 cells. The use of this transient-expression approach allowed for high levels of receptor expression and facilitated receptor purification. A concentration-and time-dependent PMA-induced phosphorylation of the ␣ 2A AR over basal was observed. Although stoichiometry cannot be accurately determined in these smallscale preparations, we were able to compare the extent of PMA-promoted phosphorylation to agonist-promoted receptor phosphorylation. [The latter process has a stoichiometry thought to be 4 mol of phosphate/mol of receptor (Eason et al. 1995; Benovic et al., 1987) ]. PMA-promoted phosphorylation was found to be ϳ80% of agonist phosphorylation. Because evaluation of ␣ 2A AR signaling and its rapid desensitization is not feasible in COS-7 cells, we subsequently studied receptors permanently expressed at lower levels in CHO cells where PMA promoted phosphorylation of the ␣ 2A AR was also demonstrated.
For functional studies, we chose to study ␣ 2A AR-mediated stimulation of intracellular calcium release. The choice of this ␣ 2 AR signaling pathway was based on several factors. First, we have found that quantitative analysis of desensitization is more readily observed in a stimulatory pathway as compared with an inhibitory pathway (such as inhibition of cAMP) because inhibition assays typically require a concomitant stimulus. Secondly, calcium responses are readily observed and quantified in real time. Also, because we have found no evidence for receptor reserve in these transfected cells when examining this signal (unpublished data), there is less concern about receptor overexpression masking desensitization of this response. The desensitization of this ␣ 2A AR function by PKC was substantial, with maximal agonist-stimulated calcium release blunted by 68%. The residues within the receptor protein that are phosphorylated by PKC are presently not known, but the third intracellular loop of the ␣ 2A AR has several serines and threonines in a favorable milieu for PKC phosphorylation. This is consistent with the fact that this loop is known to be important for functional G protein coupling (Eason and Liggett, 1996) .
It may be concluded from this study, then, that PKCmediated phosphorylation of the ␣ 2A AR results in functional desensitization and is one mechanism for heterologous desensitization of the receptor. Such regulation can be evoked by activation of receptors such as the ␣ 1 AR that couple to PLC/PKC, or by any other mechanism that activates PKC. Interestingly, because in some cells ␣ 2A AR can stimulate PLC via ␤␥ and thus activate PKC, phosphorylation by PKC may also play a role in agonist-dependent desensitization. This may be analogous to the desensitization of ␤ 2 AR by agonist, which is caused by both GRK phosphorylation and phosphorylation by the second messenger-dependent kinase protein kinase A (Hausdorff et al., 1989) . Finally, in that activation of PKC is a widespread signaling event, delineation of PKC-mediated desensitization of ␣ 2 AR function defines a mechanism by which receptor function is dynamically regulated by homeostatic and pathophysiologic processes. 
